Sign In
Buy MYOK
$224.91
+0 (+0%)
At Close: May 27, 2022
Myokardia (NASDAQ:MYOK) Hits New 52-Week Low at $43.06
07:16am, Saturday, 04'th Apr 2020
Myokardia Inc (NASDAQ:MYOK) shares hit a new 52-week low during trading on Thursday . The stock traded as low as $43.06 and last traded at $43.16, with a volume of 1064 shares trading hands. The stock
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
11:36am, Friday, 03'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2)BELLUS Health Inc (NASDAQ: BLU)Down In The Dumps (Biote
Should You Buy These 3 Biotechs Now?
10:45am, Friday, 03'rd Apr 2020
These drug developers just released new clinical trial results.
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
12:00am, Friday, 03'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 2)
BELLUS Health Inc (NASDAQ:...
Myokardia (NASDAQ:MYOK) Given "Buy" Rating at Cantor Fitzgerald
07:18am, Wednesday, 01'st Apr 2020
Myokardia (NASDAQ:MYOK)‘s stock had its “buy” rating reissued by equities researchers at Cantor Fitzgerald in a research report issued to clients and investors on Tuesday, TipRanks reports. They
Myokardia Inc (NASDAQ:MYOK) Shares Bought by Axa
09:28am, Tuesday, 31'st Mar 2020
Axa raised its position in Myokardia Inc (NASDAQ:MYOK) by 2.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 72,920 shares of the biotechnology company�
MAVERICK-HCM Phase 2 Clinical Trial Results Consistent with Tolerability Observations from Prior Studies of Mavacamten Improvement in NT-proBNP and Troponin Levels Support.
MAVERICK-HCM Phase 2 Clinical Trial Results Consistent with Tolerability Observations from Prior Studies of Mavacamten Improvement in NT-proBNP and...
The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty
04:10pm, Sunday, 29'th Mar 2020
After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus (COVID-19) news flow...
3,251 Shares in Myokardia Inc (NASDAQ:MYOK) Purchased by Great West Life Assurance Co. Can
11:00am, Saturday, 28'th Mar 2020
Great West Life Assurance Co. Can acquired a new position in shares of Myokardia Inc (NASDAQ:MYOK) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Com
MyoKardia (MYOK) Received its Third Buy in a Row
10:10am, Saturday, 28'th Mar 2020
After Cowen & Co. and Morgan Stanley gave MyoKardia (NASDAQ:
MYOK
) a Buy rating last month, the company received another Buy, this time from Credit Suisse. Analyst
Martin Auster
maintained a
Buy
rati
Myokardia Sees Unusually Large Options Volume (NASDAQ:MYOK)
05:46am, Saturday, 28'th Mar 2020
Myokardia Inc (NASDAQ:MYOK) was the target of unusually large options trading activity on Friday. Stock traders purchased 4,571 call options on the company. This is an increase of approximately 991% c
Hedge Funds Were Buying Taro Pharmaceutical Industries Ltd. (TARO) Before The Coronavirus
02:46pm, Friday, 27'th Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Hedge Fund Sentiment Was Stagnant On Inphi Corporation (IPHI) Before The Coronavirus
02:45pm, Friday, 27'th Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Hedge Funds Were Selling Watts Water Technologies Inc (WTS) Before The Coronavirus
02:45pm, Friday, 27'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
